Imunon (IMNN) Non-Current Deffered Revenue (2013 - 2021)
Imunon's Non-Current Deffered Revenue came in at $125,000 for Q3 2021, down 80.0% from $625,000 a year earlier and down 50.0% from the prior quarter.
Imunon (IMNN) Non-Current Deffered Revenue (2013 - 2021) Analysis & Trends
At the end of FY2020, Imunon's Non-Current Deffered Revenue was $500,000, down 50.0% from FY2019.
- Non-Current Deffered Revenue has declined in each of the last seven years, with a five-year compound annual growth rate of -30.1% (FY2015 to FY2020).
- Going back by year, Non-Current Deffered Revenue was $1 million in FY2019 (-33.3%), $1.5 million in FY2018 (-25.0%), $2 million in FY2017 (-20.0%) and $2.5 million in FY2016 (-16.7%).
- The Q3 2021 figure represents the lowest quarterly Non-Current Deffered Revenue in data going back to Q1 2013.
- Year-over-year, Non-Current Deffered Revenue has declined for 31 consecutive quarters, with an average decline of 51.0% over the last eight quarters.
- Over the past five years, the year-over-year decline in Non-Current Deffered Revenue ranged from 16.7% (Q4 2016) to 80.0% (Q3 2021).
- Business Quant data shows IMNN's Non-Current Deffered Revenue at $250,000 (Q2 2021), $375,000 (Q1 2021) and $500,000 (Q4 2020) in the three quarters before Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Imunon | 6.02 Mn | 6.02 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 125,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Mar 31, 2021 | 375,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Sep 30, 2020 | 625,000.00 |
| Jun 30, 2020 | 750,000.00 |
| Mar 31, 2020 | 875,000.00 |
| Dec 31, 2019 | 1.00 Mn |
| Sep 30, 2019 | 1.13 Mn |
| Jun 30, 2019 | 1.25 Mn |
| Mar 31, 2019 | 1.38 Mn |
| Dec 31, 2018 | 1.50 Mn |
| Sep 30, 2018 | 1.63 Mn |
| Jun 30, 2018 | 1.75 Mn |
| Mar 31, 2018 | 1.88 Mn |
| Dec 31, 2017 | 2.00 Mn |
| Sep 30, 2017 | 2.13 Mn |
| Jun 30, 2017 | 2.25 Mn |
| Mar 31, 2017 | 2.38 Mn |
| Dec 31, 2016 | 2.50 Mn |
Imunon Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IMNN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "IMNN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IMNN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();